Over the past week, widespread concern has emerged following viral reports suggesting that individuals with Venezuelan ancestry may be at increased risk of severe neurologic complications or death under general anesthesia. These claims—often shared without sufficient scientific context—have understandably caused fear, particularly among Venezuelan families facing upcoming surgical procedures.
This article aims to clarify what is currently known, explain why these concerns surfaced now, and provide reassurance grounded in evidence-based medicine.
Why This Topic Emerged Now
Recently, rare neurologic complications following general anesthesia were linked to a specific mitochondrial DNA mutation (ND4) identified in a very small number of patients with Venezuelan ancestry. These findings prompted professional anesthesiology societies to issue precautionary guidance.
Importantly, this does not reflect a sudden change in anesthesia safety. Rather, it represents the natural progression of medical discovery as rare events become detectable with larger exposure and improved surveillance.
Ten Key Takeaways from the Venezuelan Society of Anesthesiology (SVA)
The following points summarize key facts directly derived from the Venezuelan Society of Anesthesiology’s (SVA’s) official communications and presentations, with additional context for clarity.
1. Very few cases have been identified worldwide
Globally, only 14 patients have been identified with severe neurologic complications associated with this mutation. The first cases—previously healthy pediatric patients who failed to wake after elective surgery—were identified in Chile in July 2025, followed by cases in four additional countries.
2. U.S. anesthesiology societies emphasized rarity, not widespread risk
In response to these findings, the American Society of Anesthesiologists (ASA) and the Society for Pediatric Anesthesia (SPA) released statements highlighting:
- The extreme rarity of the mutation
- Its presence in “some individuals with Venezuelan ancestry”
- Recommendations to ask about maternal Venezuelan heritage and family history of anesthesia-related complications
The SPA further described the ND4 gene’s role in mitochondrial metabolism, providing biologic plausibility for the observed effects.
Notably, these cases remain largely anecdotal and not yet documented in peer-reviewed literature.
3. The mutation is rare even within Venezuela
Within Venezuela, the mutation remains uncommon, though it is estimated to be 15 times more prevalent in a specific population from the state of Carabobo.
At the Venezuelan Congress of Anesthesiology (November 2025), only eight total patients were identified between 2003 and 2025, five of whom underwent surgery in Venezuela.
4. This mutation is inherited exclusively through the maternal line
Because the ND4 mutation affects mitochondrial DNA, it can only be inherited maternally. Paternal inheritance is not possible.
5. The risk is specific to sevoflurane
The observed metabolic effects occur specifically with sevoflurane, the most commonly used inhaled anesthetic worldwide.
Laboratory studies demonstrate:
- ~90% reduction in oxygen consumption in ND4-mutant cells exposed to sevoflurane
- No adverse metabolic effects when mutant cells are exposed to propofol
This distinction is critical: safe alternatives exist.
6. This is a textbook example of ascertainment and base rate effects
This situation exemplifies ascertainment bias—as exposure increases, rare outcomes become detectable even though individual risk has not changed.
It also reflects the base rate effect: rare events become visible as scale increases.
Since its introduction in January 2002, sevoflurane has been administered to approximately 1.2 million patients worldwide, making detection of extremely rare events statistically inevitable.
7. Surveillance will increase—and that is expected
With increased awareness, clinicians will identify more cases. This reflects surveillance bias, not increased danger.
Updated preoperative evaluations should include:
- Family history of anesthesia complications
- Delayed emergence from anesthesia
- Maternal family history of:
- Chronic fatigue
- Ptosis
- Migraines
- Severe exercise intolerance
These features may suggest mitochondrial dysfunction, particularly in mothers and siblings of affected children.
8. Genetic testing and intraoperative monitoring are available
The ND4 mutation can be identified via:
- Blood or saliva samples
- PCR, Sanger sequencing, or next-generation sequencing (NGS)
Indirect markers (elevated lactate or lactate/pyruvate ratios) are non-specific.
When surgery proceeds without genetic confirmation:
- Deep anesthesia monitors can detect metabolic impairment within seconds, even at low doses of sevoflurane
9. The SVA is actively leading research and prevention efforts
The SVA has launched multiple initiatives, including:
- A Zone-Zero study targeting neonates and children in Carabobo to compare mitochondrial DNA with controls from another state
- A mandatory national registry for pediatric patients with delayed emergence or metabolic collapse after sevoflurane
- Retrospective review of “cold cases” previously diagnosed as cerebral palsy, hypoxic encephalopathy, or idiopathic neurologic injury
- Immediate preoperative screening changes
Patients with maternal heritage from Carabobo and positive screening responses are classified as “theoretical mitochondrial risk” and are given non-inhaled anesthetic alternatives, regardless of genetic confirmation.
10. The SVA emphasizes collaboration and patient safety
The SVA is working alongside:
- Venezuelan health authorities
- International geneticists
- Experts in mitochondrial disease from Spain, the United States, and Latin America
Their stated priority is patient safety, transparency, and global collaboration.
A Final Perspective: Why This Does Not Warrant Panic
Viral anecdotes do not define population-level risk. The events identified here were always possible—they are only now visible due to scale, surveillance, and improved detection.
This phenomenon is not unique to anesthesia. It mirrors what occurs when:
- Widespread vaccination reveals rare adverse reactions
- Expanded medication use uncovers allergies, interactions, or genetic susceptibilities
Seeing more cases does not mean risk is increasing.
For individuals of Venezuelan ancestry, these findings should be viewed as an example of medicine functioning as intended—identifying rare risks, refining care, and improving safety through awareness and prevention.
Elective surgery remains safe, and alternatives to inhaled anesthetics are readily available when appropriate. Fear should never replace informed medical decision-making.
Health and Home by Haven 
Leave a comment